CHRS

Coherus BioSciences Inc

Price:

1.04

USD

Volume:

15,428,360.00

United States | Biotechnology

-222.26 %

Upside

As of 2024-10-04, the Fair Value of Coherus BioSciences Inc (CHRS) is -1.27 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.04 USD, the upside of Coherus BioSciences Inc is -222.26%.

Note: valuation result may not be accurate due to the company's negative EPS.

1.04 USD

Stock Price

-1.27 USD

Fair Price

Peter Lynch's formula is:

CHRS Fair Value

= Earnings Growth Rate x TTM EPS
CHRS Fair Value

= 5.00 x -0.25
CHRS Fair Value

= -1.27
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings | ||||||

2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |

Net income | 89.80 | 132.20 | -287.10 | -291.80 | -237.89 | -118.96 |

YoY growth | 142.90% | 47.22% | -317.17% | -1.64% | 18.47% | -22.04% |

Market Cap (mil) | 119.82 |

P/E | |

Forward P/E |

EPS | -0.25 |

Avg earnings growth rate | -22.04% |

TTM earnings | -29.30 |